Submission of a manuscript is held to imply that it has not previously been published and is not otherwise submitted for publication (except as an abstract, which in that case has to be stated).
Authorship. All persons designated as authors must participate sufficiently in the work to take public responsibility in its contents. For criteria for authors see "Uniform requirements for manuscripts submitted to biomedical journals" Ann Intern Med 1997; 126: 36-47, or JAMA 1997; 277: 927-934. The full document is available at www.icmje.org. The journal may require authors to justify assignments of authorship. Manuscript must be accompanied by a covering letter.
Length:Articles and reviews should be kept short and written in a succint manner. Letters to the Editor and Short Communications* (brief definite reports without an Abstract and a maximum of 15 references) should not exceed 2 printed pages (i.e. ~1,200 words and one illustration or up to 3 illustrations if the number of words is proportionally reduced). Illustrative case reports with high educational value may also be submitted as a Quiz (see a recent issue of the journal).
We encourage authors to avoid repetitions and redundant information in their manuscripts. Extensive figures and tables with compilation of data can preferably be presented as e-supplements. Similarly, an extensive methodological description or a reference list exceeding 35 items can be presented in toto as e-supplement, whereas selected parts may also appear in the printed version.
*The review process is the same for full papers and brief definite reports, but brief definite reports will be published as "Short Communications". Thus, they are not second or third class but simply contain data that can be communicated in a short crisp fashion instead of being published as full reports.
Submission: Submission has to be made online at www.medicaljournals.se/acta and does not require any additional postage. Submit the manuscript (including tables and figures) as a styled Microsoft Word file and photographs as separate EPS or TIFF files. For further information please contact the Editorial office.
Language. All papers should be written in English. It is essential that the language be irreproachable. If the Editorial Board should consider it necessary, manuscripts will be subjected to language examination at the author's risk and expense.
Conflict of interest and funding: Authors are responsible for recognising and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge in the manuscript all financial support for the work and other financial or personal connections to the work.
Ethics and consent: When reporting studies on human subjects, indicate whether the procedures followed have been approved by an Ethics committee (in accordance with ethical standards on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983). Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.
Studies involving animal experiments must state that their care was in accordance with institution's or national reaearch council's guidelines for, or any national law on the care and use of laboratory animals. All animals work must have been conducted according to relevant national and international guidelines. Animal experimental procedure should be made as humane as possible and the details of anaesthetics an analgesics used should be clearly stated.
Statistics: If statistical data are an essential part of the paper the authors are requested to submit an official statement issued by a statistician (with a proper affiliation) regarding the validity of methods used.
Ethics, consent and CONSORT:When reporting studies on human subjects, indicate whether the procedures followed were approved by an ethics committee (in accordance with the Declaration of Helsinki). Information that could be used to identify patients, in the form of written descriptions, photographs and pedigrees, should not be published unless it is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Clinical trials and studies involving animal experiments must be approved by a local ethics committee, and this has to be stated in the Material and Methods section.
In order to improve the quality of randomised trials we have adapted to the CONSORT statement. Please visitwww.consort-statement.org for further instructions.
Copyright: The copyright are kept by the authors but a form for License to Publish has to be signed after acceptance but before publication in Acta Dermato-Venereologica. Authors may, of course, use the material elsewhere after publication provided that prior permission is obtained from Acta Dermato-Venereologica. Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.
Manuscripts should be type-written, double-spaced throughout, with ordinary margins. Paper should normally be divided into Abstract, Introduction, Methods, Results, Discussion and References.
Title page. A separate title page is necessary and should bear a) the title of the article, b) name of the authors, c) the institutions of origin, d) a short title and for Letters to the Editor also the corresponding author's name, address, and e-mail.
Abstract. The abstract not exceeding 150 words and preferably in one paragraph, should state the reason that promted the study, purpose, methods, the most important findings and as a conclusion the single most important finding. No headlines. In general, abbreviations are not allowed and references should not be used. A list of 3-6 key words suitable for indexing terms should be typed at the bottom of the Abstract page.
Below the abstract: Title of journal; The principal author's complete address, including e-mail. The Abstract should be typed on a separate sheet.
Pagination. Ensure that all text pages are correctly numbered in the top right-hand corner, beginning with the title page.
Headings. Please use the above-mentioned headings (all capitals).
Subheadings. Use lower case letter italicized or underlined.
References should be numbered consecutively in the order in which they are first mentioned in the text. No abstracts from proceedings or submitted manuscripts not in press are allowed. Identify references in the text using Arabic numerals in parenthesis. The style of references must follow the Vancouver system, and for the abbreviations of journal titles: please consult the Journals database, hosted at www.nlm.nih.gov.
1. Reference to periodicals: Tsutsumi R, Adachi K, Yoshida Y, Yamamoto O. Drug-induced hypersensitivity syndrome in association with varicella. Acta Derm Venereol 2015; 95: 503-504.
2. Reference to books: Handwerker H. Itch hypothesis. In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Boca Raton (FL): CRC Press; 2014: p. 2-8.
For journal article in electronic format use the following style: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. Available from: URL:http://www.cdc.gov/ncidod/EID/eid.htm
Tables and figures Line drawing and lettering should be large enough to sustain photoreduction. Tables are to be number consecutively with roman numerals. Each table should be types on a separate sheet and should have a descriptive, self-explanatory title (i.e. no unexplained abbreviations) types above the table to which is refers. List footnotes below the table, using a, b, c for referencing. Asterix are used for probability values. Place other explanatory text above the table.
All illustrations should be considered as figures. Each graph, drawing, or photograph should be numbered in sequence with Arabic numerals. All figures should have legends, listed on one separate sheet. Each figure should be identified by the name of the journal (Acta D-V), the author's name and the figure number. In case where it is not obvious, the top should be indicated. (Please see below for information regarding fees for colour images.)
Acta Dermato-Venereologica supports the efforts of the Functional Genomics Data Society to standardize the presentation of microarray data, on which further guidance can be found here. In addition, the journal strongly recommends the supplemental microarray data be deposited in a public database such as Gene Expression Omnibus or Array Express or submitted for peer-review with the initial submission of the manuscript.
All manuscripts are first reviewed by one of the Editors. Some papers may be rejected at this stage as they do not meet basic scientific principles or deal with topics beyond the scope of the journal. All other manuscripts will be entered into our peer review system and are usually sent to at least two reviewers (within or outside the Editorial Board) with special expertise in the area. The review is not blinded according to the decided policy of the journal. The manuscript will also be sent to a special statistical consultant for evaluation of the statistical methods used and the statistical results, where considered appropriate. After receiving the comments from the reviewers, it will be decided by the Editors whether the manuscript should be accepted directly, which in practice is rare, subjected to a minor or major revision before decision about publication can be made, or rejected at this point. The revised manuscript is usually, if not only minor changes required, reviewed by the reviewers, sometimes including a third reviewer, if there are special reasons, before making the final decision about publication, and if necessary after some further revision. The guidelines to the reviewers can be found on the homepage of the journal here.
€50 for Short Communication
€100 for Full Report
After a paper has been accepted, the author(s) will be charged a fee before publication:
Full reports (≤ 4000 words + ≤ 4 small illustrations (tables or figures)): €1000
Full reports (> 4000 < 6000 words and max 4 tables or figures): €1400
Full reports (> 6000 words and > 4 tables or figures): €1600
Reviews: after agreement
Short communications* (Short case reports, etc): €400
*The review process is the same for full papers and brief definite reports, but brief definite reports will be published as "Short Communications". Thus, they are not second or third class but simply contain data that can be communicated in a short, crisp fashion instead of being published as full reports.
If supplementary material should be published in connection with the accepted article the fee is 50 €/supplement.
Page proofs are sent as PDF files to the corresponding author. It is his or her full responsibility to read and check the proofs against the manuscript. The proof and the Answersheet (with corrections) should be returned to the Editorial Office within four days.
Lengthy papers may be published as supplements, the full cost being borne by the author. Supplements are subject to editorial revision before publication.
Att: Agneta Andersson
S:t Johannesgatan 22A
SE-753 12 Uppsala, Sweden